Loading organizations...
Spinal Research operates as a leading UK medical charity dedicated to advancing research into the repair and restoration of the spinal cord following injury. The organization strategically funds scientific investigations to develop effective treatments, aiming to overcome the complexities of nerve damage and promote functional recovery. Its approach involves supporting a diverse portfolio of projects, from basic science to translational studies, focused on understanding neurological mechanisms and pioneering therapeutic interventions.
The charity was established in 1981 by Stewart Yesner, a young man profoundly affected by a spinal cord injury. His personal experience and resolute determination to transform the outlook for individuals living with paralysis provided the foundational insight for Spinal Research, galvanizing efforts to challenge the previously accepted permanence of such injuries and foster scientific breakthroughs.
Ultimately, Spinal Research serves the global community of individuals living with spinal cord injuries and the medical researchers striving for solutions. The organization's overarching vision is to achieve a world where paralysis can be cured, thereby restoring hope, independence, and an improved quality of life for those impacted by spinal cord damage.
Spinal Research has 1 tracked investment across 1 company. The latest tracked deal is $5.0M Seed in Axonis Therapeutics in July 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jul 1, 2021 | Axonis Therapeutics | $5.0M Seed | Alexandria Venture Investments | America's Frontier Fund, BoxOne Ventures, Sierra Ventures, Christopher & Dana Reeve Foundation, Civilization Ventures, R3 Bio |